AbbVie and Landos Biopharma have announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for...

View the Online Magazine

Launches

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

ACG showcases concept of next generation capsule filling machine – AF330 at CPHI and PMEC 2023

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is set to unveil its next generation capsule filling...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Outcome Management: The cure for pharma’s toughest trials – by Johannes Müller, co-founder and CEO of Workpath

The pharmaceutical sector is currently grappling with significant challenges that are impacting its operations and long-term viability.  Rising cost pressures due to inflation and...

Approvals

Manufacturiung

Finance

Research & Development
Latest

U.S. FDA Rare Pediatric Disease Designation granted to Lisata Therapeutics’ LSTA1 for the treatment of osteosarcoma

The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to LSTA1, Lisata Therapeutics’ lead product candidate, for the treatment...

£17.9m awarded to Advanced Therapy Treatment Centre

The National Institute for Health and Care Research (NIHR), Innovate UK, the Advanced Therapy Treatment Centre Network and the Cell and Gene Therapy Catapult...

New collaboration to develop vaccines against deadly henipaviruses

A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against...

Cybin receives FDA Breakthrough Therapy Designation for novel psychedelic molecule for Major Depressive Disorder

Cybin, a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, has announced that the U.S....

Revolutionary chronic wound treatment could help millions

An effective treatment for chronic wounds that does not involve antibiotics, but an ionised gas to activate a wound dressing, has been developed by...

Appointments